FDA NDC Directory · JSON-LD · Markdown

Mesalamine

NDC 0093-5907 · HUMAN PRESCRIPTION DRUG · CAPSULE, DELAYED RELEASE

Labeler / ManufacturerTeva Pharmaceuticals USA, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA207873
Dosage form / routeCAPSULE, DELAYED RELEASE · ORAL
Active ingredientsMESALAMINE (400 mg/1)
Marketing started20190509
Package count1

External sources

Source: openFDA. Public-domain (CC0).